ArticleNature cancer2021

CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.

April C Watt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.